Efficacy of an Attention Guidance VR Intervention for Social Anxiety Disorder
NCT ID: NCT03683823
Last Updated: 2022-03-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
21 participants
INTERVENTIONAL
2019-02-01
2020-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multisite Virtual Reality Intervention for Speech Anxiety
NCT06593847
Attention Training and Cognitive Therapy
NCT01093313
Limited-English Proficiency (LEP) Virtual Reality (VR) Study
NCT03689868
Relevance and Salience During Attention Task
NCT05784233
Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers
NCT04059939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Attention guidance
In addition to the components included in the control intervention the experimental attention guidance condition consists of three unique components: (1) the rationale will include information about the importance of visually attending to the faces of the audience; (2) in addition to being given a speech topic, participants will be given target audience members to focus their gaze on during the speech. They will be told that they should look at and focus on the target audience member for the whole speech; (3) between speeches, the researcher will tell participants the percentage of time they were focused on the target face.
Attention guidance
Explicitly guiding attention towards faces during public speaking exposures
Control intervention
Participants will complete two intervention sessions within one week. The intervention will use a manualized protocol.
1. On the first session, participants will receive a brief standardized psychoeducation module, presented via a 15-minute video recording. This video will explain the intervention, its rationale, and the procedure.
2. Participants will then have 5 minutes to plan and outline a speech based on a topic given to them. All participants will receive the same topic. Participants will not be allowed to use the outline during the public speaking exposure trials.
3. Participants will then give six speeches that are each 3 minutes long on the same topic. Participants will give all the speeches in the immersive 360º-video environment.
4. Between speeches participants will have a 1-minute break.
Control intervention
Public speaking exposures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Attention guidance
Explicitly guiding attention towards faces during public speaking exposures
Control intervention
Public speaking exposures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Fluent in English;
3. Personal Report of Public Speaking Anxiety score \> 98;
4. Leibowitz Social Anxiety Scale \> 30;
5. Peak fear ≥ 50 on the behavioral approach task during the baseline assessment;
6. Meets DSM-5 Criteria for Social Anxiety Disorder.
Exclusion Criteria
2. Significant visual impairment precluding the use of virtual reality equipment;
3. Unstable dose of psychotropic medications within 3 weeks prior to baseline assessment;
4. Current alcohol or substance use disorders;
5. Current, or history of bipolar disorder; current, or history of psychosis;
6. Serious suicidal risk, as determined by clinical interview.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas at Austin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michael J. Telch
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas at Austin
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-04-0011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.